FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine, and can be used in treating hyperalgesia. What is used is a method of treating hyperalgesia by introduction of a pharmaceutical composition which contains an effective amount of a TRPA1 ion channel antagonist, while the TRPA1 antagonist specifically blocks TRPA1 activation and does not block activation of one or more other thermoTRP channels, such as TRPV1, TRPV2, TRPV3, TRPV4 and TRPM8. There is also offered application of the TRPA1 ion channel antagonist (Z)-4-(4-chlorophenyl)-3-methylbut-3-ene-2-oxym or N,N'-bis-(2-hydroxybenzyl)-2,5-diamino-2,5-dimethylghexane for preparing a drug for treating thermal or mechanical hyperalgia. What is offered is a method of identifying an agent inhibiting or eliminating pathological mechanical sensitivity. That is ensured by contact of the analysed compounds and a cell which expresses a flying potential of a TRPA1 ion channel receptor. It involves detecting the TRPA1 ion channel antagonist which inhibits signal activity of activated TRPA1 in a cell in response to a mechanical stimulus and has an effect on activation or signal activity of one or more thermoTRP channels.
EFFECT: inventions provide an effective acute or chronic pain relief with a component of mechanical hyperalgesia ensured by selective inhibition of mechanical transduction mediated by the TRPA1 ion channel.
18 cl, 4 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
ANALGESIC PEPTIDE OF SEA ANEMONE | 2016 |
|
RU2614759C1 |
METHOD AND DEVICE FOR IMITATION OF CHEMOSENSOR SMOKING SENSATIONS | 2012 |
|
RU2561856C1 |
AGENT WITH PROLONGED ANALGESIC ACTION AND MEDICINAL PRODUCT BASED THEREON | 2020 |
|
RU2755206C1 |
CHIMERIC PROTEIN COMPOSED OF NGF ANTAGONIST DOMAIN AND TNFα ANTAGONIST DOMAIN | 2015 |
|
RU2678810C2 |
COMPOSITION FOR REDUCTION OF TRPA1 AND TRPV1 SENSATIONS | 2013 |
|
RU2605297C2 |
SELECTING AGENTS MODULATING GASTROINTESTINAL PAIN | 2015 |
|
RU2692671C2 |
METHOD OF TREATING NEUROPATHIC PAIN AND ASSOCIATED WITH IT SYNDROMES | 2005 |
|
RU2433825C2 |
COMPOSITIONS AND METHODS OF TREATMENT OR PREVENTION OF VASOMOTOR SYMPTOMS | 2018 |
|
RU2815402C2 |
NUCLEIC ACID ENCODING HUMAN THERMOSENSITIVE TRPV1 CHANNEL WITH ALTERED ION SELECTIVITY FOR CONTROLLING CELL MEMBRANE POTENTIAL | 2021 |
|
RU2784086C1 |
(R)-PIRLINDOLE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR USE IN MEDICINE | 2014 |
|
RU2695607C2 |
Authors
Dates
2011-10-10—Published
2007-02-21—Filed